DATE ADDED TO CATALOG	PUBMEDID	FIRST AUTHOR	DATE	JOURNAL	LINK	STUDY	DISEASE/TRAIT	INITIAL SAMPLE SIZE	REPLICATION SAMPLE SIZE	REGION	CHR_ID	CHR_POS	REPORTED GENE(S)	MAPPED_GENE	UPSTREAM_GENE_ID	DOWNSTREAM_GENE_ID	SNP_GENE_IDS	UPSTREAM_GENE_DISTANCE	DOWNSTREAM_GENE_DISTANCE	STRONGEST SNP-RISK ALLELE	SNPS	MERGED	SNP_ID_CURRENT	CONTEXT	INTERGENIC	RISK ALLELE FREQUENCY	P-VALUE	PVALUE_MLOG	P-VALUE (TEXT)	OR or BETA	95% CI (TEXT)	PLATFORM [SNPS PASSING QC]	CNV	MAPPED_TRAIT	MAPPED_TRAIT_URI	STUDY ACCESSION	GENOTYPING TECHNOLOGY
2017-05-26	28120872	Li X	2017-01-25	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/28120872	Genome-wide association study identifies four SNPs associated with response to platinum-based neoadjuvant chemotherapy for cervical cancer.	Response to platinum-based neoadjuvant chemotherapy in cervical cancer	66 Han Chinese ancestry non-responder cases, 160 Han Chinese ancestry responder cases	79 Han Chinese ancestry non-responder cases, 291 Han Chinese ancestry responder cases	4q34.3	4	179391655	intergenic	LOC105377563 - LOC105377564	105377563	105377564		574329	572791	rs6812281-T	rs6812281	0	6812281	intron_variant	1	0.18	9E-9	8.045757490560675		2.37	[1.77-3.18]	Affymetrix [657178]	N	cervical carcinoma, response to platinum-based neoadjuvant chemotherapy	http://www.ebi.ac.uk/efo/EFO_0001061, http://www.ebi.ac.uk/efo/EFO_0007943	GCST004097	Genome-wide genotyping array
2017-05-26	28120872	Li X	2017-01-25	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/28120872	Genome-wide association study identifies four SNPs associated with response to platinum-based neoadjuvant chemotherapy for cervical cancer.	Response to platinum-based neoadjuvant chemotherapy in cervical cancer	66 Han Chinese ancestry non-responder cases, 160 Han Chinese ancestry responder cases	79 Han Chinese ancestry non-responder cases, 291 Han Chinese ancestry responder cases	14q32.11	14	90698719	CALM1, TTC7B, NRDE2, PSMC1, RPS18P2, RPS6KA5, RNU7- 30P, C14orf159, SNORA11B	TTC7B, LOC105370622			145567, 105370622			rs1742101-G	rs1742101	0	1742101	non_coding_transcript_exon_variant	0	0.5	7E-6	5.154901959985743		1.92	[1.45-2.56]	Affymetrix [657178]	N	cervical carcinoma, response to platinum-based neoadjuvant chemotherapy	http://www.ebi.ac.uk/efo/EFO_0001061, http://www.ebi.ac.uk/efo/EFO_0007943	GCST004097	Genome-wide genotyping array
2017-05-26	28120872	Li X	2017-01-25	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/28120872	Genome-wide association study identifies four SNPs associated with response to platinum-based neoadjuvant chemotherapy for cervical cancer.	Response to platinum-based neoadjuvant chemotherapy in cervical cancer	66 Han Chinese ancestry non-responder cases, 160 Han Chinese ancestry responder cases	79 Han Chinese ancestry non-responder cases, 291 Han Chinese ancestry responder cases	16q23.3	16	83706502	MIR3182, HSBP1, MLYCO, OSGIN1, NECAB2, SLC38A8, RNA5SP432, MBTPS1, HSDL1, CDH13, DNAAF1, TAF1C, ADAD2	LOC105371366, CDH13			105371366, 1012			rs1364121-A	rs1364121	0	1364121	intron_variant	0	0.25	3E-6	5.522878745280337		1.98	[1.49-2.64]	Affymetrix [657178]	N	cervical carcinoma, response to platinum-based neoadjuvant chemotherapy	http://www.ebi.ac.uk/efo/EFO_0001061, http://www.ebi.ac.uk/efo/EFO_0007943	GCST004097	Genome-wide genotyping array
2011-11-24	22020760	Won HH	2011-10-21	Cancer	www.ncbi.nlm.nih.gov/pubmed/22020760	Polymorphic markers associated with severe oxaliplatin-induced, chronic peripheral neuropathy in colon cancer patients.	Response to platinum-based agents	96 colon cancer cases	247 colon cancer cases	7q21.3	7	97600466	TAC1	RN7SKP104 - TAC1	106480865	6863		1206	131493	rs10486003-?	rs10486003	0	10486003	intergenic_variant	1	NR	5E-7	6.301029995663981		3.13	[1.92-5.26]	Affymetrix [656843]	N	response to platinum based chemotherapy	http://www.ebi.ac.uk/efo/EFO_0004647	GCST001291	Genome-wide genotyping array
2011-11-24	22020760	Won HH	2011-10-21	Cancer	www.ncbi.nlm.nih.gov/pubmed/22020760	Polymorphic markers associated with severe oxaliplatin-induced, chronic peripheral neuropathy in colon cancer patients.	Response to platinum-based agents	96 colon cancer cases	247 colon cancer cases	6p25.3	6	1573378	FOXC1, GMDS	LOC107986555			107986555			rs2338-?	rs2338	0	2338	intergenic_variant	0	NR	5E-6	5.301029995663981		2.27	[1.58-3.26]	Affymetrix [656843]	N	response to platinum based chemotherapy	http://www.ebi.ac.uk/efo/EFO_0004647	GCST001291	Genome-wide genotyping array
2011-11-24	22020760	Won HH	2011-10-21	Cancer	www.ncbi.nlm.nih.gov/pubmed/22020760	Polymorphic markers associated with severe oxaliplatin-induced, chronic peripheral neuropathy in colon cancer patients.	Response to platinum-based agents	96 colon cancer cases	247 colon cancer cases	5q11.2	5	52724562	ITGA1, PELO	LOC105378964			105378964			rs830884-?	rs830884	0	830884	intron_variant	0	NR	2E-6	5.698970004336019		3.13	[1.85-5.26]	Affymetrix [656843]	N	response to platinum based chemotherapy	http://www.ebi.ac.uk/efo/EFO_0004647	GCST001291	Genome-wide genotyping array
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)	428 Japanese ancestry cases, 743 Japanese ancestry controls	NA	15q24.2	15	75157333	RPL36AP45	LOC107987225 - RPL36AP45	107987225	441727		1797	29318	rs4886670-A	rs4886670	0	4886670	intergenic_variant	1	0.227	1E-6	6.0	(Allelic model)	1.605	[1.330-1.937]	Illumina [733202]	N	response to platinum based chemotherapy, response to antineoplastic agent	http://www.ebi.ac.uk/efo/EFO_0004647, http://purl.obolibrary.org/obo/GO_0097327	GCST001998	Genome-wide genotyping array
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)	428 Japanese ancestry cases, 743 Japanese ancestry controls	NA	19q12	19	30446936	ZNF536	ZNF536			9745			rs33428-G	rs33428	0	33428	intron_variant	0	0.403	3E-6	5.522878745280337	(Dominant model)	1.375	[1.160-1.629]	Illumina [733202]	N	response to platinum based chemotherapy, response to antineoplastic agent	http://www.ebi.ac.uk/efo/EFO_0004647, http://purl.obolibrary.org/obo/GO_0097327	GCST001998	Genome-wide genotyping array
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)	428 Japanese ancestry cases, 743 Japanese ancestry controls	NA	14q11.2	14	22468664	TRA	TRA, LOC105370401			6955, 105370401			rs12589282-G	rs12589282	0	12589282	intron_variant	0	0.437	4E-6	5.3979400086720375	(Recessive model)	1.48	[1.25-1.752]	Illumina [733202]	N	response to platinum based chemotherapy, response to antineoplastic agent	http://www.ebi.ac.uk/efo/EFO_0004647, http://purl.obolibrary.org/obo/GO_0097327	GCST001998	Genome-wide genotyping array
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)	428 Japanese ancestry cases, 743 Japanese ancestry controls	NA	3p14.1	3	66475539	LRIG1	LRIG1			26018			rs3845905-G	rs3845905	0	3845905	intron_variant	0	0.85	4E-6	5.3979400086720375	(Allelic model)	1.894	[1.433-2.503]	Illumina [733202]	N	response to platinum based chemotherapy, response to antineoplastic agent	http://www.ebi.ac.uk/efo/EFO_0004647, http://purl.obolibrary.org/obo/GO_0097327	GCST001998	Genome-wide genotyping array
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)	428 Japanese ancestry cases, 743 Japanese ancestry controls	NA	5q35.1	5	170115596	FOXI1	FOXI1 - KRT18P41	2299	345430		5871	25008	rs1895302-C	rs1895302	0	1895302	intergenic_variant	1	0.478	7E-6	5.154901959985743	(Dominant model)	1.34	[1.132-1.587]	Illumina [733202]	N	response to platinum based chemotherapy, response to antineoplastic agent	http://www.ebi.ac.uk/efo/EFO_0004647, http://purl.obolibrary.org/obo/GO_0097327	GCST001998	Genome-wide genotyping array
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (all platinum-based drugs)	428 Japanese ancestry cases, 743 Japanese ancestry controls	NA	1p36.12	1	21511262	ALPL	ALPL			249			rs16825455-T	rs16825455	0	16825455	intron_variant	0	0.605	9E-6	5.045757490560675	(Dominant model)	1.425	[1.193-1.702]	Illumina [733202]	N	response to platinum based chemotherapy, response to antineoplastic agent	http://www.ebi.ac.uk/efo/EFO_0004647, http://purl.obolibrary.org/obo/GO_0097327	GCST001998	Genome-wide genotyping array
2016-12-11	27047539	Fridley BL	2016-03-22	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27047539	Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence.	Response to carboplatin in ovarian cancer (MTT IC50)	74 lymphoblastoid cell lines	NA	18q21.1	18	48561565	CTIF	CTIF			9811			rs8091660-?	rs8091660	0	8091660	intron_variant	0	NR	9E-6	5.045757490560675				Illumina [6243550] (imputed)	N	response to platinum based chemotherapy, ovarian carcinoma, cytotoxicity measurement	http://www.ebi.ac.uk/efo/EFO_0004647, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0006952	GCST003440	Genome-wide genotyping array
2016-12-11	27047539	Fridley BL	2016-03-22	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27047539	Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence.	Response to paclitaxel in ovarian cancer (Caspase 3/7 EC50)	74 lymphoblastoid cell lines	NA	6q12	6	65027022	EYS	EYS			346007			rs201083182-?	rs201083182	0	201083182	intron_variant	0	NR	2E-6	5.698970004336019				Illumina [6243550] (imputed)	N	response to platinum based chemotherapy, ovarian carcinoma, cytotoxicity measurement	http://www.ebi.ac.uk/efo/EFO_0004647, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0006952	GCST003439	Genome-wide genotyping array
2016-12-11	27047539	Fridley BL	2016-03-22	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27047539	Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence.	Response to paclitaxel in ovarian cancer (Caspase 3/7 EC50)	74 lymphoblastoid cell lines	NA	5q23.2	5	122442912	MGC32805, SNCAIP	SNCAIP, MGC32805			9627, 153163			rs3842595-?	rs3842595	0	3842595	intron_variant	0	NR	3E-7	6.522878745280337				Illumina [6243550] (imputed)	N	response to platinum based chemotherapy, ovarian carcinoma, cytotoxicity measurement	http://www.ebi.ac.uk/efo/EFO_0004647, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0006952	GCST003439	Genome-wide genotyping array
2016-12-11	27047539	Fridley BL	2016-03-22	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27047539	Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence.	Response to carboplatin in ovarian cancer (MTT IC50)	74 lymphoblastoid cell lines	NA	4q21.21	4	78088155	FRAS1	FRAS1			80144			rs150303591-?	rs150303591	0	150303591	intron_variant	0	NR	6E-7	6.221848749616356				Illumina [6243550] (imputed)	N	response to platinum based chemotherapy, ovarian carcinoma, cytotoxicity measurement	http://www.ebi.ac.uk/efo/EFO_0004647, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0006952	GCST003440	Genome-wide genotyping array
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	261 Japanese ancestry cases, 262 Japanese ancestry controls	NA	13q12.11	13	20476436	CRYL1	CRYL1			51084			rs7989332-G	rs7989332	0	7989332	intron_variant	0	0.738	5E-6	5.301029995663981	(Allelic model)	2.056	[1.507-2.806]	Illumina [733202]	N	response to carboplatin, response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0097328, http://purl.obolibrary.org/obo/GO_0097327	GCST002004	Genome-wide genotyping array
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	261 Japanese ancestry cases, 262 Japanese ancestry controls	NA	5p13.2	5	35799892	SPEF2	LOC105374724, SPEF2			105374724, 79925			rs3822735-G	rs3822735	0	3822735	intron_variant	0	0.752	2E-6	5.698970004336019	(Dominant model)	2.062	[1.500-2.834]	Illumina [733202]	N	response to carboplatin, response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0097328, http://purl.obolibrary.org/obo/GO_0097327	GCST002004	Genome-wide genotyping array
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	261 Japanese ancestry cases, 262 Japanese ancestry controls	NA	15q21.3	15	55657884	PRTG	PRTG			283659			rs11071200-T	rs11071200	0	11071200	intron_variant	0	0.008	9E-7	6.045757490560675	(Dominant model)	8.241	[2.888-23.520]	Illumina [733202]	N	response to carboplatin, response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0097328, http://purl.obolibrary.org/obo/GO_0097327	GCST002004	Genome-wide genotyping array
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	261 Japanese ancestry cases, 262 Japanese ancestry controls	NA	3p14.1	3	66475539	LRIG1	LRIG1			26018			rs3845905-G	rs3845905	0	3845905	intron_variant	0	0.828	6E-6	5.221848749616356	(Allelic model)	2.433	[1.645-3.598]	Illumina [733202]	N	response to carboplatin, response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0097328, http://purl.obolibrary.org/obo/GO_0097327	GCST002004	Genome-wide genotyping array
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	261 Japanese ancestry cases, 262 Japanese ancestry controls	NA	16q23.3	16	81741193	CMIP	LOC105369213			105369213			rs12446319-A	rs12446319	0	12446319	intron_variant	0	0.143	9E-6	5.045757490560675	(Allelic model)	2.026	[1.48-2.774]	Illumina [733202]	N	response to carboplatin, response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0097328, http://purl.obolibrary.org/obo/GO_0097327	GCST002004	Genome-wide genotyping array
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	261 Japanese ancestry cases, 262 Japanese ancestry controls	NA	3p14.3	3	58041470	FLNB	FLNB			2317			rs1623879-G	rs1623879	0	1623879	intron_variant	0	0.321	4E-6	5.3979400086720375	(Recessive model)	1.669	[1.297-2.148]	Illumina [733202]	N	response to carboplatin, response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0097328, http://purl.obolibrary.org/obo/GO_0097327	GCST002004	Genome-wide genotyping array
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	261 Japanese ancestry cases, 262 Japanese ancestry controls	NA	15q24.1	15	74839978	ULK3	ULK3			25989			rs936229-G	rs936229	0	936229	intron_variant	0	0.595	4E-6	5.3979400086720375	(Dominant model)	1.685	[1.302-2.18]	Illumina [733202]	N	response to carboplatin, response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0097328, http://purl.obolibrary.org/obo/GO_0097327	GCST002004	Genome-wide genotyping array
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	261 Japanese ancestry cases, 262 Japanese ancestry controls	NA	8p23.2	8	4247625	CSMD1	CSMD1			64478			rs1714746-G	rs1714746	0	1714746	intron_variant	0	0.435	7E-6	5.154901959985743	(Recessive model)	1.61	[1.261-2.056]	Illumina [733202]	N	response to carboplatin, response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0097328, http://purl.obolibrary.org/obo/GO_0097327	GCST002004	Genome-wide genotyping array
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (carboplatin)	261 Japanese ancestry cases, 262 Japanese ancestry controls	NA	1p13.3	1	108850215	AKNAD1	AKNAD1			254268			rs1277203-A	rs1277203	0	1277203	intron_variant	0	0.626	9E-6	5.045757490560675	(Recessive model)	1.615	[1.243-2.098]	Illumina [733202]	N	response to carboplatin, response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0097328, http://purl.obolibrary.org/obo/GO_0097327	GCST002004	Genome-wide genotyping array
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)	150 Japanese ancestry cases, 166 Japanese ancestry controls	NA	9q34.2	9	134233655	RXRA	LOC107987039 - LOC105376310	107987039	105376310		5449	60275	rs10785877-T	rs10785877	0	10785877	intergenic_variant	1	0.66	7E-7	6.154901959985743	(Allelic model)	2.58	[1.766-3.769]	Illumina [733202]	N	response to carboplatin, response to paclitaxel, response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0097328, http://purl.obolibrary.org/obo/GO_1901555, http://purl.obolibrary.org/obo/GO_0097327	GCST002006	Genome-wide genotyping array
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)	150 Japanese ancestry cases, 166 Japanese ancestry controls	NA	1p36.21	1	15013464	RP1-21O18.1	KAZN			23254			rs6429703-T	rs6429703	0	6429703	intron_variant	0	0.078	8E-6	5.096910013008056	(Allelic model)	2.942	[1.802-4.804]	Illumina [733202]	N	response to carboplatin, response to paclitaxel, response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0097328, http://purl.obolibrary.org/obo/GO_1901555, http://purl.obolibrary.org/obo/GO_0097327	GCST002006	Genome-wide genotyping array
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)	150 Japanese ancestry cases, 166 Japanese ancestry controls	NA	12q22	12	95096472	FGD6	FGD6			55785			rs12310399-A	rs12310399	0	12310399	intron_variant	0	0.567	2E-7	6.698970004336019	(Recessive model)	1.852	[1.329-2.58]	Illumina [733202]	N	response to carboplatin, response to paclitaxel, response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0097328, http://purl.obolibrary.org/obo/GO_1901555, http://purl.obolibrary.org/obo/GO_0097327	GCST002006	Genome-wide genotyping array
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)	150 Japanese ancestry cases, 166 Japanese ancestry controls	NA	19q12	19	28375689	LOC100420587	LOC107985269 - LOC100420587	107985269	100420587		58329	59699	rs995834-C	rs995834	0	995834	intron_variant	1	0.425	1E-6	6.0	(Dominant model)	1.871	[1.364-2.566]	Illumina [733202]	N	response to carboplatin, response to paclitaxel, response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0097328, http://purl.obolibrary.org/obo/GO_1901555, http://purl.obolibrary.org/obo/GO_0097327	GCST002006	Genome-wide genotyping array
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)	150 Japanese ancestry cases, 166 Japanese ancestry controls	NA	1p22.2	1	89557237	LRRC8B	LRRC8B			23507			rs922107-G	rs922107	0	922107	intron_variant	0	0.211	3E-6	5.522878745280337	(Recessive model)	1.788	[1.25-2.558]	Illumina [733202]	N	response to carboplatin, response to paclitaxel, response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0097328, http://purl.obolibrary.org/obo/GO_1901555, http://purl.obolibrary.org/obo/GO_0097327	GCST002006	Genome-wide genotyping array
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)	150 Japanese ancestry cases, 166 Japanese ancestry controls	NA	7p14.1	7	37522765	LOC442668	ELMO1 - NECAP1P1	9844	442668		73356	60090	rs1425132-T	rs1425132	0	1425132	intergenic_variant	1	0.666	5E-6	5.301029995663981	(Recessive model)	1.43	[1.013-2.017]	Illumina [733202]	N	response to carboplatin, response to paclitaxel, response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0097328, http://purl.obolibrary.org/obo/GO_1901555, http://purl.obolibrary.org/obo/GO_0097327	GCST002006	Genome-wide genotyping array
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (paclitaxel + carboplatin)	150 Japanese ancestry cases, 166 Japanese ancestry controls	NA	22q12.3	22	36121884	APOL3	LOC102723507			102723507			rs1476029-A	rs1476029	0	1476029	intergenic_variant	0	0.015	8E-6	5.096910013008056	(Allelic model)	6.426	[2.429-17.00]	Illumina [733202]	N	response to carboplatin, response to paclitaxel, response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0097328, http://purl.obolibrary.org/obo/GO_1901555, http://purl.obolibrary.org/obo/GO_0097327	GCST002006	Genome-wide genotyping array
2015-04-16	21844884	Wheeler HE	2011-08-16	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/21844884	Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.	Response to platinum-based chemotherapy (carboplatin)	176 Sub-Saharan African ancestry lymphoblastoid cell lines, 83 African ancestry lymphoblastoid cell lines, 175 East Asian ancestry lymphoblastoid cell lines, 174 European ancestry lymphoblastoid cell lines	NA	2p24.3	2	15369022	NBAS	NBAS			51594			rs7572081-?	rs7572081	0	7572081	intron_variant	0		5E-7	6.301029995663981				NR [~ 3000000] (imputed)	N	response to carboplatin	http://purl.obolibrary.org/obo/GO_0097328	GCST001204	Genome-wide genotyping array
2015-04-16	21844884	Wheeler HE	2011-08-16	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/21844884	Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.	Response to platinum-based chemotherapy (carboplatin)	176 Sub-Saharan African ancestry lymphoblastoid cell lines, 83 African ancestry lymphoblastoid cell lines, 175 East Asian ancestry lymphoblastoid cell lines, 174 European ancestry lymphoblastoid cell lines	NA	4p15.32	4	17433467	intergenic	RPS7P6 - QDPR	100270869	5860		5118	52926	rs2518590-?	rs2518590	0	2518590	intergenic_variant	1		8E-6	5.096910013008056				NR [~ 3000000] (imputed)	N	response to carboplatin	http://purl.obolibrary.org/obo/GO_0097328	GCST001204	Genome-wide genotyping array
2015-04-16	21844884	Wheeler HE	2011-08-16	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/21844884	Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.	Response to platinum-based chemotherapy (carboplatin)	176 Sub-Saharan African ancestry lymphoblastoid cell lines, 83 African ancestry lymphoblastoid cell lines, 175 East Asian ancestry lymphoblastoid cell lines, 174 European ancestry lymphoblastoid cell lines	NA	12p12.2	12	20383437	PDE3A	PDE3A			5139			rs4326884-?	rs4326884	0	4326884	intron_variant	0		8E-7	6.096910013008056				NR [~ 3000000] (imputed)	N	response to carboplatin	http://purl.obolibrary.org/obo/GO_0097328	GCST001204	Genome-wide genotyping array
2015-04-16	21844884	Wheeler HE	2011-08-16	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/21844884	Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.	Response to platinum-based chemotherapy (carboplatin)	176 Sub-Saharan African ancestry lymphoblastoid cell lines, 83 African ancestry lymphoblastoid cell lines, 175 East Asian ancestry lymphoblastoid cell lines, 174 European ancestry lymphoblastoid cell lines	NA	1p36.11	1	24179559	IL28RA	IFNLR1			163702			rs3893319-?	rs3893319	0	3893319	intron_variant	0		1E-6	6.0				NR [~ 3000000] (imputed)	N	response to carboplatin	http://purl.obolibrary.org/obo/GO_0097328	GCST001204	Genome-wide genotyping array
2015-04-16	21844884	Wheeler HE	2011-08-16	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/21844884	Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.	Response to platinum-based chemotherapy (carboplatin)	176 Sub-Saharan African ancestry lymphoblastoid cell lines, 83 African ancestry lymphoblastoid cell lines, 175 East Asian ancestry lymphoblastoid cell lines, 174 European ancestry lymphoblastoid cell lines	NA	6p21.33	6	31101750	intergenic	HCG22 - C6orf15	285834	29113		41860	9473	rs9263567-?	rs9263567	0	9263567	intergenic_variant	1		2E-6	5.698970004336019				NR [~ 3000000] (imputed)	N	response to carboplatin	http://purl.obolibrary.org/obo/GO_0097328	GCST001204	Genome-wide genotyping array
2015-04-16	21844884	Wheeler HE	2011-08-16	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/21844884	Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.	Response to platinum-based chemotherapy (carboplatin)	176 Sub-Saharan African ancestry lymphoblastoid cell lines, 83 African ancestry lymphoblastoid cell lines, 175 East Asian ancestry lymphoblastoid cell lines, 174 European ancestry lymphoblastoid cell lines	NA	16q12.1	16	51681964	intergenic	RN7SKP142 - LOC105371257	106480877	105371257		10401	37115	rs1381451-?	rs1381451	0	1381451	intergenic_variant	1		7E-6	5.154901959985743				NR [~ 3000000] (imputed)	N	response to carboplatin	http://purl.obolibrary.org/obo/GO_0097328	GCST001204	Genome-wide genotyping array
2015-04-16	21844884	Wheeler HE	2011-08-16	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/21844884	Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.	Response to platinum-based chemotherapy (carboplatin)	176 Sub-Saharan African ancestry lymphoblastoid cell lines, 83 African ancestry lymphoblastoid cell lines, 175 East Asian ancestry lymphoblastoid cell lines, 174 European ancestry lymphoblastoid cell lines	NA	18q21.31	18	57970480	intergenic	LOC107985146 - HMGN1P30	107985146	100132992		8853	47177	rs12457254-?	rs12457254	0	12457254	regulatory_region_variant	1		5E-6	5.301029995663981				NR [~ 3000000] (imputed)	N	response to carboplatin	http://purl.obolibrary.org/obo/GO_0097328	GCST001204	Genome-wide genotyping array
2015-04-16	21844884	Wheeler HE	2011-08-16	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/21844884	Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.	Response to platinum-based chemotherapy (carboplatin)	176 Sub-Saharan African ancestry lymphoblastoid cell lines, 83 African ancestry lymphoblastoid cell lines, 175 East Asian ancestry lymphoblastoid cell lines, 174 European ancestry lymphoblastoid cell lines	NA	19q13.42	19	54667327	LILRB4	LILRB4			11006			rs11574583-?	rs11574583	0	11574583	non_coding_transcript_exon_variant	0		6E-6	5.221848749616356				NR [~ 3000000] (imputed)	N	response to carboplatin	http://purl.obolibrary.org/obo/GO_0097328	GCST001204	Genome-wide genotyping array
2015-04-16	21844884	Wheeler HE	2011-08-16	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/21844884	Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.	Response to platinum-based chemotherapy (carboplatin)	176 Sub-Saharan African ancestry lymphoblastoid cell lines, 83 African ancestry lymphoblastoid cell lines, 175 East Asian ancestry lymphoblastoid cell lines, 174 European ancestry lymphoblastoid cell lines	NA	9q21.13	9	73877511	intergenic	LOC100420008 - LOC105376086	100420008	105376086		4190	46524	rs17059531-?	rs17059531	0	17059531	intergenic_variant	1		6E-6	5.221848749616356				NR [~ 3000000] (imputed)	N	response to carboplatin	http://purl.obolibrary.org/obo/GO_0097328	GCST001204	Genome-wide genotyping array
2015-04-16	21844884	Wheeler HE	2011-08-16	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/21844884	Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.	Response to platinum-based chemotherapy (carboplatin)	176 Sub-Saharan African ancestry lymphoblastoid cell lines, 83 African ancestry lymphoblastoid cell lines, 175 East Asian ancestry lymphoblastoid cell lines, 174 European ancestry lymphoblastoid cell lines	NA	15q25.3	15	85533958	AKAP13	AKAP13			11214			rs2279168-?	rs2279168	0	2279168	3_prime_UTR_variant	0		9E-6	5.045757490560675				NR [~ 3000000] (imputed)	N	response to carboplatin	http://purl.obolibrary.org/obo/GO_0097328	GCST001204	Genome-wide genotyping array
2015-04-16	21844884	Wheeler HE	2011-08-16	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/21844884	Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.	Response to platinum-based chemotherapy (carboplatin)	176 Sub-Saharan African ancestry lymphoblastoid cell lines, 83 African ancestry lymphoblastoid cell lines, 175 East Asian ancestry lymphoblastoid cell lines, 174 European ancestry lymphoblastoid cell lines	NA	11q21	11	96796409	intergenic	LOC100131233 - MED28P5	100131233	106479053		153156	203980	rs1155410-?	rs1155410	0	1155410	intergenic_variant	1		2E-6	5.698970004336019				NR [~ 3000000] (imputed)	N	response to carboplatin	http://purl.obolibrary.org/obo/GO_0097328	GCST001204	Genome-wide genotyping array
2015-04-16	21844884	Wheeler HE	2011-08-16	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/21844884	Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.	Response to platinum-based chemotherapy (carboplatin)	176 Sub-Saharan African ancestry lymphoblastoid cell lines, 83 African ancestry lymphoblastoid cell lines, 175 East Asian ancestry lymphoblastoid cell lines, 174 European ancestry lymphoblastoid cell lines	NA	4q26	4	115920168	intergenic	PGAM4P2 - KRT18P21	100131611	132391		155407	489	rs7668874-?	rs7668874	0	7668874	intergenic_variant	1		6E-6	5.221848749616356				NR [~ 3000000] (imputed)	N	response to carboplatin	http://purl.obolibrary.org/obo/GO_0097328	GCST001204	Genome-wide genotyping array
2015-04-16	21844884	Wheeler HE	2011-08-16	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/21844884	Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.	Response to platinum-based chemotherapy (carboplatin)	176 Sub-Saharan African ancestry lymphoblastoid cell lines, 83 African ancestry lymphoblastoid cell lines, 175 East Asian ancestry lymphoblastoid cell lines, 174 European ancestry lymphoblastoid cell lines	NA	5q23.1	5	120081372	intergenic	LOC105379144 - RNU6-718P	105379144	106481406		103417	256177	rs255788-?	rs255788	0	255788	intergenic_variant	1		2E-6	5.698970004336019				NR [~ 3000000] (imputed)	N	response to carboplatin	http://purl.obolibrary.org/obo/GO_0097328	GCST001204	Genome-wide genotyping array
2015-04-16	21844884	Wheeler HE	2011-08-16	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/21844884	Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.	Response to platinum-based chemotherapy (carboplatin)	176 Sub-Saharan African ancestry lymphoblastoid cell lines, 83 African ancestry lymphoblastoid cell lines, 175 East Asian ancestry lymphoblastoid cell lines, 174 European ancestry lymphoblastoid cell lines	NA	6q24.1	6	138600907	intergenic	NHSL1			57224			rs7758889-?	rs7758889	0	7758889	intron_variant	0		9E-7	6.045757490560675				NR [~ 3000000] (imputed)	N	response to carboplatin	http://purl.obolibrary.org/obo/GO_0097328	GCST001204	Genome-wide genotyping array
2015-04-16	21844884	Wheeler HE	2011-08-16	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/21844884	Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.	Response to platinum-based chemotherapy (carboplatin)	176 Sub-Saharan African ancestry lymphoblastoid cell lines, 83 African ancestry lymphoblastoid cell lines, 175 East Asian ancestry lymphoblastoid cell lines, 174 European ancestry lymphoblastoid cell lines	NA	7q36.1	7	152694814	intergenic	XRCC2 - ATP5F1P3	7516	644333		18649	54067	rs13232006-?	rs13232006	0	13232006	intergenic_variant	1		4E-6	5.3979400086720375				NR [~ 3000000] (imputed)	N	response to carboplatin	http://purl.obolibrary.org/obo/GO_0097328	GCST001204	Genome-wide genotyping array
2015-04-16	21844884	Wheeler HE	2011-08-16	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/21844884	Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.	Response to platinum-based chemotherapy (carboplatin)	176 Sub-Saharan African ancestry lymphoblastoid cell lines, 83 African ancestry lymphoblastoid cell lines, 175 East Asian ancestry lymphoblastoid cell lines, 174 European ancestry lymphoblastoid cell lines	NA	5q34	5	168484035	RARS	WWC1 - RARS	23286	5917		11732	2423	rs244899-?	rs244899	0	244899	intergenic_variant	1		1E-6	6.0				NR [~ 3000000] (imputed)	N	response to carboplatin	http://purl.obolibrary.org/obo/GO_0097328	GCST001204	Genome-wide genotyping array
2015-04-16	21844884	Wheeler HE	2011-08-16	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/21844884	Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.	Response to platinum-based chemotherapy (carboplatin)	176 Sub-Saharan African ancestry lymphoblastoid cell lines, 83 African ancestry lymphoblastoid cell lines, 175 East Asian ancestry lymphoblastoid cell lines, 174 European ancestry lymphoblastoid cell lines	NA	2q32.1	2	182257311	PDE1A	PDE1A			5136			rs6758334-?	rs6758334	0	6758334	intron_variant	0		9E-6	5.045757490560675				NR [~ 3000000] (imputed)	N	response to carboplatin	http://purl.obolibrary.org/obo/GO_0097328	GCST001204	Genome-wide genotyping array
2015-04-16	21844884	Wheeler HE	2011-08-16	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/21844884	Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.	Response to platinum-based chemotherapy (carboplatin)	176 Sub-Saharan African ancestry lymphoblastoid cell lines, 83 African ancestry lymphoblastoid cell lines, 175 East Asian ancestry lymphoblastoid cell lines, 174 European ancestry lymphoblastoid cell lines	NA	1q44	1	247618267	intergenic	LOC102724446			102724446			rs1144815-?	rs1144815	0	1144815	intron_variant	0		9E-6	5.045757490560675				NR [~ 3000000] (imputed)	N	response to carboplatin	http://purl.obolibrary.org/obo/GO_0097328	GCST001204	Genome-wide genotyping array
2015-04-16	21844884	Wheeler HE	2011-08-16	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/21844884	Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.	Response to platinum-based chemotherapy (cisplatin)	176 Sub-Saharan African ancestry lymphoblastoid cell lines, 83 African ancestry lymphoblastoid cell lines, 175 East Asian ancestry lymphoblastoid cell lines, 174 European ancestry lymphoblastoid cell lines	NA	17p12	17	14614150	intergenic	LOC107985080 - LOC107984996	107985080	107984996		192493	1971	rs12600394-?	rs12600394	0	12600394	intergenic_variant	1		2E-6	5.698970004336019				NR [~ 3000000] (imputed)	N	response to cisplatin	http://purl.obolibrary.org/obo/GO_0072718	GCST001201	Genome-wide genotyping array
2015-04-16	21844884	Wheeler HE	2011-08-16	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/21844884	Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.	Response to platinum-based chemotherapy (cisplatin)	176 Sub-Saharan African ancestry lymphoblastoid cell lines, 83 African ancestry lymphoblastoid cell lines, 175 East Asian ancestry lymphoblastoid cell lines, 174 European ancestry lymphoblastoid cell lines	NA	13q21.32	13	66586549	PCDH9	LOC105370247, PCDH9			105370247, 5101			rs11148708-?	rs11148708	0	11148708	intron_variant	0		3E-6	5.522878745280337				NR [~ 3000000] (imputed)	N	response to cisplatin	http://purl.obolibrary.org/obo/GO_0072718	GCST001201	Genome-wide genotyping array
2015-04-16	21844884	Wheeler HE	2011-08-16	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/21844884	Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.	Response to platinum-based chemotherapy (cisplatin)	176 Sub-Saharan African ancestry lymphoblastoid cell lines, 83 African ancestry lymphoblastoid cell lines, 175 East Asian ancestry lymphoblastoid cell lines, 174 European ancestry lymphoblastoid cell lines	NA	13q21.1	13	55584874	intergenic	MIR5007 - HNF4GP1	100846996	100130462		410326	411615	rs9527419-?	rs9527419	0	9527419	intergenic_variant	1		6E-6	5.221848749616356				NR [~ 3000000] (imputed)	N	response to cisplatin	http://purl.obolibrary.org/obo/GO_0072718	GCST001201	Genome-wide genotyping array
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)	176 Japanese ancestry cases, 471 Japanese ancestry controls	NA	7p21.1	7	16822225	AGR2	AGR2 - LOC100287613	10551	100287613		17111	27766	rs10253216-T	rs10253216	0	10253216	intron_variant	1	0.468	2E-7	6.698970004336019	(Dominant model)	1.478	[1.155-1.891]	Illumina [733202]	N	response to cisplatin, response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0072718, http://purl.obolibrary.org/obo/GO_0097327	GCST002007	Genome-wide genotyping array
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)	176 Japanese ancestry cases, 471 Japanese ancestry controls	NA	4q13.1	4	62558371	LOC644534	HMGN1P11 - EXOC5P1	644534	644548		46802	258455	rs11944965-T	rs11944965	0	11944965	intergenic_variant	1	0.678	2E-6	5.698970004336019	(Dominant model)	1.986	[1.475-2.676]	Illumina [733202]	N	response to cisplatin, response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0072718, http://purl.obolibrary.org/obo/GO_0097327	GCST002007	Genome-wide genotyping array
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)	176 Japanese ancestry cases, 471 Japanese ancestry controls	NA	18q23	18	76776324	ZNF236	CCND3P2 - LOC100131655	106480307	100131655		24483	18408	rs2406342-T	rs2406342	0	2406342	intergenic_variant	1	0.475	2E-6	5.698970004336019	(Dominant model)	1.697	[1.323-2.177]	Illumina [733202]	N	response to cisplatin, response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0072718, http://purl.obolibrary.org/obo/GO_0097327	GCST002007	Genome-wide genotyping array
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)	176 Japanese ancestry cases, 471 Japanese ancestry controls	NA	20p12.3	20	7771719	SFRS13AP2	LOC105372518 - SRSF10P2	105372518	171472		46723	59782	rs6077251-T	rs6077251	0	6077251	intergenic_variant	1	0.153	3E-6	5.522878745280337	(Allelic model)	2.065	[1.537-2.773]	Illumina [733202]	N	response to cisplatin, response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0072718, http://purl.obolibrary.org/obo/GO_0097327	GCST002007	Genome-wide genotyping array
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)	176 Japanese ancestry cases, 471 Japanese ancestry controls	NA	8p21.1	8	27882900	SCARA5	SCARA5			286133			rs11774576-A	rs11774576	0	11774576	intron_variant	0	0.581	3E-6	5.522878745280337	(Dominant model)	1.699	[1.307-2.208]	Illumina [733202]	N	response to cisplatin, response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0072718, http://purl.obolibrary.org/obo/GO_0097327	GCST002007	Genome-wide genotyping array
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)	176 Japanese ancestry cases, 471 Japanese ancestry controls	NA	11p15.1	11	18800490	PTPN5	PTPN5 - LOC100420123	84867	100420123		7769	35715	rs4627050-G	rs4627050	0	4627050	intergenic_variant	1	0.649	4E-6	5.3979400086720375	(Allelic model)	1.932	[1.452-2.572]	Illumina [733202]	N	response to cisplatin, response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0072718, http://purl.obolibrary.org/obo/GO_0097327	GCST002007	Genome-wide genotyping array
2013-11-14	23648065	Low SK	2013-05-04	Cancer Sci	www.ncbi.nlm.nih.gov/pubmed/23648065	Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.	Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)	176 Japanese ancestry cases, 471 Japanese ancestry controls	NA	1p13.3	1	107760300	VAV3	VAV3			10451			rs12142335-A	rs12142335	0	12142335	intron_variant	0	0.004	8E-6	5.096910013008056	(Dominant model)	9.713	[3.175-29.71]	Illumina [733202]	N	response to cisplatin, response to antineoplastic agent	http://purl.obolibrary.org/obo/GO_0072718, http://purl.obolibrary.org/obo/GO_0097327	GCST002007	Genome-wide genotyping array
2015-04-16	21844884	Wheeler HE	2011-08-16	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/21844884	Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.	Response to platinum-based chemotherapy (cisplatin)	176 Sub-Saharan African ancestry lymphoblastoid cell lines, 83 African ancestry lymphoblastoid cell lines, 175 East Asian ancestry lymphoblastoid cell lines, 174 European ancestry lymphoblastoid cell lines	NA	17p11.2	17	16861664	intergenic	COTL1P1 - LOC101929105	27170	101929105		5548	18593	rs7210837-?	rs7210837	0	7210837	non_coding_transcript_exon_variant	1		6E-7	6.221848749616356				NR [~ 3000000] (imputed)	N	response to cisplatin	http://purl.obolibrary.org/obo/GO_0072718	GCST001201	Genome-wide genotyping array
2015-04-16	21844884	Wheeler HE	2011-08-16	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/21844884	Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.	Response to platinum-based chemotherapy (cisplatin)	176 Sub-Saharan African ancestry lymphoblastoid cell lines, 83 African ancestry lymphoblastoid cell lines, 175 East Asian ancestry lymphoblastoid cell lines, 174 European ancestry lymphoblastoid cell lines	NA	11p15.1	11	20247844	intergenic	LOC105376583 - HTATIP2	105376583	10553		47915	115841	rs1520896-?	rs1520896	0	1520896	intergenic_variant	1		1E-6	6.0				NR [~ 3000000] (imputed)	N	response to cisplatin	http://purl.obolibrary.org/obo/GO_0072718	GCST001201	Genome-wide genotyping array
2015-04-16	21844884	Wheeler HE	2011-08-16	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/21844884	Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.	Response to platinum-based chemotherapy (cisplatin)	176 Sub-Saharan African ancestry lymphoblastoid cell lines, 83 African ancestry lymphoblastoid cell lines, 175 East Asian ancestry lymphoblastoid cell lines, 174 European ancestry lymphoblastoid cell lines	NA	1p36.11	1	24171333	IL28RA	IFNLR1			163702			rs6698365-?	rs6698365	0	6698365	intron_variant	0		1E-6	6.0				NR [~ 3000000] (imputed)	N	response to cisplatin	http://purl.obolibrary.org/obo/GO_0072718	GCST001201	Genome-wide genotyping array
2015-04-16	21844884	Wheeler HE	2011-08-16	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/21844884	Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.	Response to platinum-based chemotherapy (cisplatin)	176 Sub-Saharan African ancestry lymphoblastoid cell lines, 83 African ancestry lymphoblastoid cell lines, 175 East Asian ancestry lymphoblastoid cell lines, 174 European ancestry lymphoblastoid cell lines	NA	2p23.3	2	25431180	DTNB	LOC101929272, DTNB			101929272, 1838			rs7605235-?	rs7605235	0	7605235	intron_variant	0		7E-6	5.154901959985743				NR [~ 3000000] (imputed)	N	response to cisplatin	http://purl.obolibrary.org/obo/GO_0072718	GCST001201	Genome-wide genotyping array
2015-04-16	21844884	Wheeler HE	2011-08-16	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/21844884	Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.	Response to platinum-based chemotherapy (cisplatin)	176 Sub-Saharan African ancestry lymphoblastoid cell lines, 83 African ancestry lymphoblastoid cell lines, 175 East Asian ancestry lymphoblastoid cell lines, 174 European ancestry lymphoblastoid cell lines	NA	6p21.33	6	31101750	intergenic	HCG22 - C6orf15	285834	29113		41860	9473	rs9263567-?	rs9263567	0	9263567	intergenic_variant	1		5E-6	5.301029995663981				NR [~ 3000000] (imputed)	N	response to cisplatin	http://purl.obolibrary.org/obo/GO_0072718	GCST001201	Genome-wide genotyping array
2015-04-16	21844884	Wheeler HE	2011-08-16	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/21844884	Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.	Response to platinum-based chemotherapy (cisplatin)	176 Sub-Saharan African ancestry lymphoblastoid cell lines, 83 African ancestry lymphoblastoid cell lines, 175 East Asian ancestry lymphoblastoid cell lines, 174 European ancestry lymphoblastoid cell lines	NA	21q22.11	21	31034797	intergenic	LOC105372774			105372774			rs2833197-?	rs2833197	0	2833197	intergenic_variant	0		9E-6	5.045757490560675				NR [~ 3000000] (imputed)	N	response to cisplatin	http://purl.obolibrary.org/obo/GO_0072718	GCST001201	Genome-wide genotyping array
2015-04-16	21844884	Wheeler HE	2011-08-16	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/21844884	Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.	Response to platinum-based chemotherapy (cisplatin)	176 Sub-Saharan African ancestry lymphoblastoid cell lines, 83 African ancestry lymphoblastoid cell lines, 175 East Asian ancestry lymphoblastoid cell lines, 174 European ancestry lymphoblastoid cell lines	NA	18q21.1	18	50482070	intergenic	RPLP0P11 - MAPK4	647094	5596		23211	77711	rs9960150-?	rs9960150	0	9960150	intergenic_variant	1		5E-6	5.301029995663981				NR [~ 3000000] (imputed)	N	response to cisplatin	http://purl.obolibrary.org/obo/GO_0072718	GCST001201	Genome-wide genotyping array
2015-04-16	21844884	Wheeler HE	2011-08-16	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/21844884	Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.	Response to platinum-based chemotherapy (cisplatin)	176 Sub-Saharan African ancestry lymphoblastoid cell lines, 83 African ancestry lymphoblastoid cell lines, 175 East Asian ancestry lymphoblastoid cell lines, 174 European ancestry lymphoblastoid cell lines	NA	19q13.32	19	46980665	GRLF1	ARHGAP35			2909			rs10164289-?	rs10164289	0	10164289	intron_variant	0		7E-6	5.154901959985743				NR [~ 3000000] (imputed)	N	response to cisplatin	http://purl.obolibrary.org/obo/GO_0072718	GCST001201	Genome-wide genotyping array
2015-04-16	21844884	Wheeler HE	2011-08-16	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/21844884	Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.	Response to platinum-based chemotherapy (cisplatin)	176 Sub-Saharan African ancestry lymphoblastoid cell lines, 83 African ancestry lymphoblastoid cell lines, 175 East Asian ancestry lymphoblastoid cell lines, 174 European ancestry lymphoblastoid cell lines	NA	13q21.1	13	55804290	intergenic	MIR5007 - HNF4GP1	100846996	100130462		629742	192199	rs2997105-?	rs2997105	0	2997105	intergenic_variant	1		4E-6	5.3979400086720375				NR [~ 3000000] (imputed)	N	response to cisplatin	http://purl.obolibrary.org/obo/GO_0072718	GCST001201	Genome-wide genotyping array
2015-04-16	21844884	Wheeler HE	2011-08-16	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/21844884	Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.	Response to platinum-based chemotherapy (cisplatin)	176 Sub-Saharan African ancestry lymphoblastoid cell lines, 83 African ancestry lymphoblastoid cell lines, 175 East Asian ancestry lymphoblastoid cell lines, 174 European ancestry lymphoblastoid cell lines	NA	13q21.31	13	63490455	intergenic	LINC00376 - LOC105370237	104355293	105370237		162361	95063	rs1340490-?	rs1340490	0	1340490	intergenic_variant	1		3E-6	5.522878745280337				NR [~ 3000000] (imputed)	N	response to cisplatin	http://purl.obolibrary.org/obo/GO_0072718	GCST001201	Genome-wide genotyping array
2015-04-16	21844884	Wheeler HE	2011-08-16	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/21844884	Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.	Response to platinum-based chemotherapy (cisplatin)	176 Sub-Saharan African ancestry lymphoblastoid cell lines, 83 African ancestry lymphoblastoid cell lines, 175 East Asian ancestry lymphoblastoid cell lines, 174 European ancestry lymphoblastoid cell lines	NA	4q13.2	4	66748851	intergenic	RPS23P3 - LOC105377262	100271091	105377262		317330	114013	rs4860223-?	rs4860223	0	4860223	intergenic_variant	1		1E-6	6.0				NR [~ 3000000] (imputed)	N	response to cisplatin	http://purl.obolibrary.org/obo/GO_0072718	GCST001201	Genome-wide genotyping array
2015-04-16	21844884	Wheeler HE	2011-08-16	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/21844884	Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.	Response to platinum-based chemotherapy (cisplatin)	176 Sub-Saharan African ancestry lymphoblastoid cell lines, 83 African ancestry lymphoblastoid cell lines, 175 East Asian ancestry lymphoblastoid cell lines, 174 European ancestry lymphoblastoid cell lines	NA	2p12	2	75642702	intergenic	EVA1A - MRPL19	84141	9801		72980	4081	rs12105510-?	rs12105510	0	12105510	intergenic_variant	1		6E-6	5.221848749616356				NR [~ 3000000] (imputed)	N	response to cisplatin	http://purl.obolibrary.org/obo/GO_0072718	GCST001201	Genome-wide genotyping array
2015-04-16	21844884	Wheeler HE	2011-08-16	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/21844884	Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.	Response to platinum-based chemotherapy (cisplatin)	176 Sub-Saharan African ancestry lymphoblastoid cell lines, 83 African ancestry lymphoblastoid cell lines, 175 East Asian ancestry lymphoblastoid cell lines, 174 European ancestry lymphoblastoid cell lines	NA	4q21.1	4	76842845	intergenic	LOC105377289 - LOC100421494	105377289	100421494		40272	42754	rs10518159-?	rs10518159	0	10518159	intergenic_variant	1		1E-6	6.0				NR [~ 3000000] (imputed)	N	response to cisplatin	http://purl.obolibrary.org/obo/GO_0072718	GCST001201	Genome-wide genotyping array
2015-04-16	21844884	Wheeler HE	2011-08-16	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/21844884	Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.	Response to platinum-based chemotherapy (cisplatin)	176 Sub-Saharan African ancestry lymphoblastoid cell lines, 83 African ancestry lymphoblastoid cell lines, 175 East Asian ancestry lymphoblastoid cell lines, 174 European ancestry lymphoblastoid cell lines	NA	12q21.31	12	81995345	intergenic	LOC101928449 - LOC105369873	101928449	105369873		2212	139550	rs11115148-?	rs11115148	0	11115148	intergenic_variant	1		2E-6	5.698970004336019				NR [~ 3000000] (imputed)	N	response to cisplatin	http://purl.obolibrary.org/obo/GO_0072718	GCST001201	Genome-wide genotyping array
2015-04-16	21844884	Wheeler HE	2011-08-16	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/21844884	Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.	Response to platinum-based chemotherapy (cisplatin)	176 Sub-Saharan African ancestry lymphoblastoid cell lines, 83 African ancestry lymphoblastoid cell lines, 175 East Asian ancestry lymphoblastoid cell lines, 174 European ancestry lymphoblastoid cell lines	NA	16q24.1	16	86270655	intergenic	LINC01081			101154687			rs7191751-?	rs7191751	0	7191751	intron_variant	0		2E-6	5.698970004336019				NR [~ 3000000] (imputed)	N	response to cisplatin	http://purl.obolibrary.org/obo/GO_0072718	GCST001201	Genome-wide genotyping array
2015-04-16	21844884	Wheeler HE	2011-08-16	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/21844884	Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.	Response to platinum-based chemotherapy (cisplatin)	176 Sub-Saharan African ancestry lymphoblastoid cell lines, 83 African ancestry lymphoblastoid cell lines, 175 East Asian ancestry lymphoblastoid cell lines, 174 European ancestry lymphoblastoid cell lines	NA	6q24.1	6	138600907	intergenic	NHSL1			57224			rs7758889-?	rs7758889	0	7758889	intron_variant	0		7E-7	6.154901959985743				NR [~ 3000000] (imputed)	N	response to cisplatin	http://purl.obolibrary.org/obo/GO_0072718	GCST001201	Genome-wide genotyping array
2015-04-16	21844884	Wheeler HE	2011-08-16	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/21844884	Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.	Response to platinum-based chemotherapy (cisplatin)	176 Sub-Saharan African ancestry lymphoblastoid cell lines, 83 African ancestry lymphoblastoid cell lines, 175 East Asian ancestry lymphoblastoid cell lines, 174 European ancestry lymphoblastoid cell lines	NA	3q28	3	188701738	LPP	LPP			4026			rs1254774-?	rs1254774	0	1254774	intron_variant	0		4E-6	5.3979400086720375				NR [~ 3000000] (imputed)	N	response to cisplatin	http://purl.obolibrary.org/obo/GO_0072718	GCST001201	Genome-wide genotyping array
2015-04-16	21844884	Wheeler HE	2011-08-16	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/21844884	Genome-wide meta-analysis identifies variants associated with platinating agent susceptibility across populations.	Response to platinum-based chemotherapy (cisplatin)	176 Sub-Saharan African ancestry lymphoblastoid cell lines, 83 African ancestry lymphoblastoid cell lines, 175 East Asian ancestry lymphoblastoid cell lines, 174 European ancestry lymphoblastoid cell lines	NA	2q37.3	2	238729659	intergenic	LOC105373962			105373962			rs4545955-?	rs4545955	0	4545955	intron_variant	0		7E-6	5.154901959985743				NR [~ 3000000] (imputed)	N	response to cisplatin	http://purl.obolibrary.org/obo/GO_0072718	GCST001201	Genome-wide genotyping array
2016-12-11	27047539	Fridley BL	2016-03-22	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27047539	Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence.	Response to carboplatin and paclitaxel in ovarian cancer (MTT IC50)	74 lymphoblastoid cell lines	NA	3q24	3	143384827	SLC9A9	SLC9A9			285195			rs201023017-?	rs201023017	0	201023017	intron_variant	0	NR	6E-7	6.221848749616356				Illumina [6243550] (imputed)	N	response to platinum based chemotherapy, ovarian carcinoma, cytotoxicity measurement, response to paclitaxel	http://www.ebi.ac.uk/efo/EFO_0004647, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0006952, http://purl.obolibrary.org/obo/GO_1901555	GCST003444	Genome-wide genotyping array
2016-12-11	27047539	Fridley BL	2016-03-22	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27047539	Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence.	Response to carboplatin and paclitaxel in ovarian cancer (MTT IC50)	74 lymphoblastoid cell lines	NA	10q26.11	10	119607441	TIAL1	LOC105378512 - RAD1P1	105378512	100128880		7635	13434	rs66696671-?	rs66696671	0	66696671	intergenic_variant	1	NR	7E-7	6.154901959985743				Illumina [6243550] (imputed)	N	response to platinum based chemotherapy, ovarian carcinoma, cytotoxicity measurement, response to paclitaxel	http://www.ebi.ac.uk/efo/EFO_0004647, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0006952, http://purl.obolibrary.org/obo/GO_1901555	GCST003444	Genome-wide genotyping array
2016-12-11	27047539	Fridley BL	2016-03-22	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27047539	Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence.	Response to carboplatin and paclitaxel in ovarian cancer (Caspase 3/7 EC50)	74 lymphoblastoid cell lines	NA	1q44	1	247193430	ZNF731P	ZNF731P - MIR3916	729806	100500849		2413	8537	rs12025262-?	rs12025262	0	12025262	intron_variant	1	NR	7E-7	6.154901959985743				Illumina [6243550] (imputed)	N	response to platinum based chemotherapy, ovarian carcinoma, cytotoxicity measurement, response to paclitaxel	http://www.ebi.ac.uk/efo/EFO_0004647, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0006952, http://purl.obolibrary.org/obo/GO_1901555	GCST003443	Genome-wide genotyping array
2016-12-11	27047539	Fridley BL	2016-03-22	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27047539	Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence.	Response to carboplatin and paclitaxel in ovarian cancer (Caspase 3/7 EC50)	74 lymphoblastoid cell lines	NA	13q21.2	13	61317943	PCDH20	MIR3169 - PCDH20	100422973	64881		118063	91020	rs10674174-?	rs10674174	0	10674174	intergenic_variant	1	NR	8E-7	6.096910013008056				Illumina [6243550] (imputed)	N	response to platinum based chemotherapy, ovarian carcinoma, cytotoxicity measurement, response to paclitaxel	http://www.ebi.ac.uk/efo/EFO_0004647, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0006952, http://purl.obolibrary.org/obo/GO_1901555	GCST003443	Genome-wide genotyping array
2016-12-11	27047539	Fridley BL	2016-03-22	Front Genet	www.ncbi.nlm.nih.gov/pubmed/27047539	Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence.	Response to carboplatin and paclitaxel in ovarian cancer (Caspase 3/7 EC50)	74 lymphoblastoid cell lines	NA	2p23.2	2	28097166	BRE	BRE			9577			rs7572644-?	rs7572644	0	7572644	intron_variant	0	NR	6E-6	5.221848749616356				Illumina [6243550] (imputed)	N	response to platinum based chemotherapy, ovarian carcinoma, cytotoxicity measurement, response to paclitaxel	http://www.ebi.ac.uk/efo/EFO_0004647, http://www.ebi.ac.uk/efo/EFO_0001075, http://www.ebi.ac.uk/efo/EFO_0006952, http://purl.obolibrary.org/obo/GO_1901555	GCST003443	Genome-wide genotyping array
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases	NA	2q35	2	217010416	DIRC3, TNP1	LOC101928278			101928278			rs12165173-?	rs12165173	0	12165173	intergenic_variant	0	NR	5E-6	5.301029995663981	(adjusted for dose, GFR & AST)	1.06	unit decrease (EA)	Illumina [610255]	N	Malignant epithelial tumor of ovary, response to carboplatin	http://www.orpha.net/ORDO/Orphanet_398934, http://purl.obolibrary.org/obo/GO_0097328	GCST005351	Genome-wide genotyping array
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases	NA	10q22.1	10	69910197	COL13A1	COL13A1			1305			rs12412836-?	rs12412836	0	12412836	intron_variant	0	NR	4E-6	5.3979400086720375	(adjusted for dose, GFR & AST)	0.75	unit decrease (EA)	Illumina [610255]	N	Malignant epithelial tumor of ovary, response to carboplatin	http://www.orpha.net/ORDO/Orphanet_398934, http://purl.obolibrary.org/obo/GO_0097328	GCST005351	Genome-wide genotyping array
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases	NA	10q23.1	10	85041429	FAM190B, LOC100507470	LOC107984249 - LINC01519	107984249	101929624		48380	151992	rs12571637-?	rs12571637	0	12571637	intergenic_variant	1	NR	7E-6	5.154901959985743	(adjusted for dose, GFR & AST)	1.59	unit decrease (EA)	Illumina [610255]	N	Malignant epithelial tumor of ovary, response to carboplatin	http://www.orpha.net/ORDO/Orphanet_398934, http://purl.obolibrary.org/obo/GO_0097328	GCST005351	Genome-wide genotyping array
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases	NA	14q32.2	14	96778118	PAPOLA, VRK1	LOC105370646			105370646			rs17280534-?	rs17280534	0	17280534	intron_variant	0	NR	6E-6	5.221848749616356	(adjusted for dose, GFR & AST)	1.49	unit decrease (EA)	Illumina [610255]	N	Malignant epithelial tumor of ovary, response to carboplatin	http://www.orpha.net/ORDO/Orphanet_398934, http://purl.obolibrary.org/obo/GO_0097328	GCST005351	Genome-wide genotyping array
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases	NA	7q36.1	7	151487834	RHEB	RHEB			6009			rs17635967-?	rs17635967	0	17635967	intron_variant	0	NR	6E-6	5.221848749616356	(adjusted for dose, GFR & AST)	1.49	unit decrease (EA)	Illumina [610255]	N	Malignant epithelial tumor of ovary, response to carboplatin	http://www.orpha.net/ORDO/Orphanet_398934, http://purl.obolibrary.org/obo/GO_0097328	GCST005351	Genome-wide genotyping array
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases	NA	6q21	6	105789630	PREP, PRDM1	LOC105377923			105377923			rs2202766-?	rs2202766	0	2202766	intron_variant	0	NR	7E-6	5.154901959985743	(adjusted for dose, GFR & AST)	1.47	unit decrease (EA)	Illumina [610255]	N	Malignant epithelial tumor of ovary, response to carboplatin	http://www.orpha.net/ORDO/Orphanet_398934, http://purl.obolibrary.org/obo/GO_0097328	GCST005351	Genome-wide genotyping array
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases	NA	15q14	15	38490292	RASGRP1	RASGRP1			10125			rs4313770-?	rs4313770	0	4313770	3_prime_UTR_variant	0	NR	6E-6	5.221848749616356	(adjusted for dose, GFR & AST)	1.49	unit decrease (EA)	Illumina [610255]	N	Malignant epithelial tumor of ovary, response to carboplatin	http://www.orpha.net/ORDO/Orphanet_398934, http://purl.obolibrary.org/obo/GO_0097328	GCST005351	Genome-wide genotyping array
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases	NA	4p15.2	4	27184810	STIM2, MIR4275	STIM2 - LOC101929199	57620	101929199		159429	32669	rs4692174-?	rs4692174	0	4692174	intergenic_variant	1	NR	7E-6	5.154901959985743	(adjusted for dose, GFR & AST)	0.88	unit decrease (EA)	Illumina [610255]	N	Malignant epithelial tumor of ovary, response to carboplatin	http://www.orpha.net/ORDO/Orphanet_398934, http://purl.obolibrary.org/obo/GO_0097328	GCST005351	Genome-wide genotyping array
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases	NA	20q11.23	20	38323940	BPI	BPI			671			rs5741804-?	rs5741804	0	5741804	missense_variant	0	NR	9E-6	5.045757490560675	(adjusted for dose, GFR & AST)	1.49	unit decrease (EA)	Illumina [610255]	N	Malignant epithelial tumor of ovary, response to carboplatin	http://www.orpha.net/ORDO/Orphanet_398934, http://purl.obolibrary.org/obo/GO_0097328	GCST005351	Genome-wide genotyping array
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases	NA	11q12.2	11	61792563	C11orf10	TMEM258			746			rs7102974-?	rs7102974	0	7102974	5_prime_UTR_variant	0	NR	6E-6	5.221848749616356	(adjusted for dose, GFR & AST)	1.49	unit decrease (EA)	Illumina [610255]	N	Malignant epithelial tumor of ovary, response to carboplatin	http://www.orpha.net/ORDO/Orphanet_398934, http://purl.obolibrary.org/obo/GO_0097328	GCST005351	Genome-wide genotyping array
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases	NA	18q11.2	18	27347470	RP11-739N10	LOC105372040 - UBA52P9	105372040	100271344		1359	7952	rs7230264-?	rs7230264	0	7230264	intron_variant	1	NR	9E-7	6.045757490560675	(adjusted for dose, GFR & AST)	0.65	unit decrease (EA)	Illumina [610255]	N	Malignant epithelial tumor of ovary, response to carboplatin	http://www.orpha.net/ORDO/Orphanet_398934, http://purl.obolibrary.org/obo/GO_0097328	GCST005351	Genome-wide genotyping array
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases	NA	10p12.1	10	25602315	GPR158	GPR158 - GPN3P1	57512	100302689		86	44762	rs7909167-?	rs7909167	0	7909167	intergenic_variant	1	NR	6E-6	5.221848749616356	(adjusted for dose, GFR & AST)	1.49	unit decrease (EA)	Illumina [610255]	N	Malignant epithelial tumor of ovary, response to carboplatin	http://www.orpha.net/ORDO/Orphanet_398934, http://purl.obolibrary.org/obo/GO_0097328	GCST005351	Genome-wide genotyping array
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases	NA	10q24.2	10	99850776	ABCC2	ABCC2			1244			rs8187707-?	rs8187707	0	8187707	synonymous_variant	0	NR	5E-6	5.301029995663981	(adjusted for dose, GFR & AST)	1.21	unit decrease (EA)	Illumina [610255]	N	Malignant epithelial tumor of ovary, response to carboplatin	http://www.orpha.net/ORDO/Orphanet_398934, http://purl.obolibrary.org/obo/GO_0097328	GCST005351	Genome-wide genotyping array
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases	NA	21q21.3	21	25631797	MRPL39, JAM2	MRPL39 - JAM2	54148	58494		23939	7485	rs9982086-?	rs9982086	0	9982086	intergenic_variant	1	NR	9E-6	5.045757490560675	(adjusted for dose, GFR & AST)	1.06	unit decrease (EA)	Illumina [610255]	N	Malignant epithelial tumor of ovary, response to carboplatin	http://www.orpha.net/ORDO/Orphanet_398934, http://purl.obolibrary.org/obo/GO_0097328	GCST005351	Genome-wide genotyping array
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases	NA	13q33.3	13	107290084	FAM155A	FAM155A			728215			rs9558996-?	rs9558996	0	9558996	intron_variant	0	NR	5E-6	5.301029995663981		1.285	unit increase (EA)	Illumina [610255]	N	Malignant epithelial tumor of ovary, response to carboplatin	http://www.orpha.net/ORDO/Orphanet_398934, http://purl.obolibrary.org/obo/GO_0097328	GCST005351	Genome-wide genotyping array
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases	NA	3p14.3	3	55376983	CACNA2D3, WNT5A	LOC105377098 - WNT5A	105377098	7474		76057	88732	rs11130471-?	rs11130471	0	11130471	intergenic_variant	1	NR	9E-6	5.045757490560675		1.641	unit decrease (EA)	Illumina [610255]	N	Malignant epithelial tumor of ovary, response to carboplatin	http://www.orpha.net/ORDO/Orphanet_398934, http://purl.obolibrary.org/obo/GO_0097328	GCST005351	Genome-wide genotyping array
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases	NA	4q31.21	4	145811502	ZNF827	ZNF827			152485			rs17806780-?	rs17806780	0	17806780	intron_variant	0	NR	9E-6	5.045757490560675		1.484	unit increase (EA)	Illumina [610255]	N	Malignant epithelial tumor of ovary, response to carboplatin	http://www.orpha.net/ORDO/Orphanet_398934, http://purl.obolibrary.org/obo/GO_0097328	GCST005351	Genome-wide genotyping array
2018-03-05	29367611	Gao B	2018-01-24	Sci Rep	www.ncbi.nlm.nih.gov/pubmed/29367611	Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer.	Carboplatin disposition in epthelial ovarian cancer	42 European ancestry cases, 14 Asian ancestry cases	NA	5q31.2	5	138109311	WNT8A, NME5	WNT8A - NME5	7478	8382		16411	5861	rs12516561-?	rs12516561	0	12516561	intergenic_variant	1	NR	4E-6	5.3979400086720375		1.671	unit increase (EA)	Illumina [610255]	N	Malignant epithelial tumor of ovary, response to carboplatin	http://www.orpha.net/ORDO/Orphanet_398934, http://purl.obolibrary.org/obo/GO_0097328	GCST005351	Genome-wide genotyping array
2017-04-10	28039263	Wheeler HE	2016-12-30	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/28039263	Variants in WFS1 and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated Ototoxicity.	Cisplatin-induced ototoxicity	511 European ancestry testicular cancer survivor individuals	238 children	4p16.1	4	6274903	WFS1	WFS1			7466			rs62283056-C	rs62283056	0	62283056	intron_variant	0	NR	5E-8	7.301029995663981		5.438	z score decrease	Illumina [5060354] (imputed)	N	ototoxicity, response to cisplatin	http://www.ebi.ac.uk/efo/EFO_0006951, http://purl.obolibrary.org/obo/GO_0072718	GCST003898	Genome-wide genotyping array
2017-04-10	28039263	Wheeler HE	2016-12-30	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/28039263	Variants in WFS1 and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated Ototoxicity.	Cisplatin-induced ototoxicity	511 European ancestry testicular cancer survivor individuals	238 children	2p21	2	43088349	intergenic	LOC107985876 - RNU6-242P	107985876	106481254		18693	3039	rs62137541-T	rs62137541	0	62137541	regulatory_region_variant	1	NR	1E-7	7.0		5.28	z score decrease	Illumina [5060354] (imputed)	N	ototoxicity, response to cisplatin	http://www.ebi.ac.uk/efo/EFO_0006951, http://purl.obolibrary.org/obo/GO_0072718	GCST003898	Genome-wide genotyping array
2017-04-10	28039263	Wheeler HE	2016-12-30	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/28039263	Variants in WFS1 and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated Ototoxicity.	Cisplatin-induced ototoxicity	511 European ancestry testicular cancer survivor individuals	238 children	2p21	2	43091570	intergenic	RNU6-242P - LOC100506047	106481254	100506047		76	4300	rs7562946-A	rs7562946	0	7562946	intergenic_variant	1	NR	4E-7	6.3979400086720375		5.053	z score decrease	Illumina [5060354] (imputed)	N	ototoxicity, response to cisplatin	http://www.ebi.ac.uk/efo/EFO_0006951, http://purl.obolibrary.org/obo/GO_0072718	GCST003898	Genome-wide genotyping array
2017-04-10	28039263	Wheeler HE	2016-12-30	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/28039263	Variants in WFS1 and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated Ototoxicity.	Cisplatin-induced ototoxicity	511 European ancestry testicular cancer survivor individuals	238 children	8p23.1	8	11427626	FAM167A	FAM167A-AS1, FAM167A			83656, 83648			rs12156238-C	rs12156238	0	12156238	intron_variant	0	NR	5E-7	6.301029995663981		5.032	z score increase	Illumina [5060354] (imputed)	N	ototoxicity, response to cisplatin	http://www.ebi.ac.uk/efo/EFO_0006951, http://purl.obolibrary.org/obo/GO_0072718	GCST003898	Genome-wide genotyping array
2017-04-10	28039263	Wheeler HE	2016-12-30	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/28039263	Variants in WFS1 and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated Ototoxicity.	Cisplatin-induced ototoxicity	511 European ancestry testicular cancer survivor individuals	238 children	2p21	2	43092840	intergenic	RNU6-242P - LOC100506047	106481254	100506047		1346	3030	rs3179891-A	rs3179891	0	3179891	regulatory_region_variant	1	NR	5E-7	6.301029995663981		5.026	z score increase	Illumina [5060354] (imputed)	N	ototoxicity, response to cisplatin	http://www.ebi.ac.uk/efo/EFO_0006951, http://purl.obolibrary.org/obo/GO_0072718	GCST003898	Genome-wide genotyping array
2017-04-10	28039263	Wheeler HE	2016-12-30	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/28039263	Variants in WFS1 and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated Ototoxicity.	Cisplatin-induced ototoxicity	511 European ancestry testicular cancer survivor individuals	238 children	2p21	2	43088710	intergenic	LOC107985876 - RNU6-242P	107985876	106481254		19054	2678	rs7578467-T	rs7578467	0	7578467	regulatory_region_variant	1	NR	5E-7	6.301029995663981		5.019	z score increase	Illumina [5060354] (imputed)	N	ototoxicity, response to cisplatin	http://www.ebi.ac.uk/efo/EFO_0006951, http://purl.obolibrary.org/obo/GO_0072718	GCST003898	Genome-wide genotyping array
2017-04-10	28039263	Wheeler HE	2016-12-30	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/28039263	Variants in WFS1 and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated Ototoxicity.	Cisplatin-induced ototoxicity	511 European ancestry testicular cancer survivor individuals	238 children	10q26.3	10	128974127	intergenic	LOC728327 - LOC107984279	728327	107984279		57839	266258	rs10829534-T	rs10829534	0	10829534	intergenic_variant	1	NR	5E-6	5.301029995663981		4.582	z score decrease	Illumina [5060354] (imputed)	N	ototoxicity, response to cisplatin	http://www.ebi.ac.uk/efo/EFO_0006951, http://purl.obolibrary.org/obo/GO_0072718	GCST003898	Genome-wide genotyping array
2017-04-10	28039263	Wheeler HE	2016-12-30	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/28039263	Variants in WFS1 and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated Ototoxicity.	Cisplatin-induced ototoxicity	511 European ancestry testicular cancer survivor individuals	238 children	1p31.1	1	76987908	ST6GALNAC5	ST6GALNAC5			81849			rs2143582-T	rs2143582	0	2143582	intron_variant	0	NR	5E-6	5.301029995663981		4.554	z score decrease	Illumina [5060354] (imputed)	N	ototoxicity, response to cisplatin	http://www.ebi.ac.uk/efo/EFO_0006951, http://purl.obolibrary.org/obo/GO_0072718	GCST003898	Genome-wide genotyping array
2017-04-10	28039263	Wheeler HE	2016-12-30	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/28039263	Variants in WFS1 and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated Ototoxicity.	Cisplatin-induced ototoxicity	511 European ancestry testicular cancer survivor individuals	238 children	4q13.1	4	60987687	intergenic	MIR548AG1 - LOC105377249	100616450	105377249		65003	156001	rs13148643-T	rs13148643	0	13148643	intergenic_variant	1	NR	5E-6	5.301029995663981		4.554	z score increase	Illumina [5060354] (imputed)	N	ototoxicity, response to cisplatin	http://www.ebi.ac.uk/efo/EFO_0006951, http://purl.obolibrary.org/obo/GO_0072718	GCST003898	Genome-wide genotyping array
2017-04-10	28039263	Wheeler HE	2016-12-30	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/28039263	Variants in WFS1 and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated Ototoxicity.	Cisplatin-induced ototoxicity	511 European ancestry testicular cancer survivor individuals	238 children	5q15	5	97197765	intergenic	RIOK2 - YTHDF1P1	55781	402220		14464	170822	rs1000083-T	rs1000083	0	1000083	intron_variant	1	NR	5E-6	5.301029995663981		4.55	z score decrease	Illumina [5060354] (imputed)	N	ototoxicity, response to cisplatin	http://www.ebi.ac.uk/efo/EFO_0006951, http://purl.obolibrary.org/obo/GO_0072718	GCST003898	Genome-wide genotyping array
2017-04-10	28039263	Wheeler HE	2016-12-30	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/28039263	Variants in WFS1 and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated Ototoxicity.	Cisplatin-induced ototoxicity	511 European ancestry testicular cancer survivor individuals	238 children	2p21	2	43093990	intergenic	RNU6-242P - LOC100506047	106481254	100506047		2496	1880	rs12615153-T	rs12615153	0	12615153	intergenic_variant	1	NR	6E-6	5.221848749616356		4.529	z score decrease	Illumina [5060354] (imputed)	N	ototoxicity, response to cisplatin	http://www.ebi.ac.uk/efo/EFO_0006951, http://purl.obolibrary.org/obo/GO_0072718	GCST003898	Genome-wide genotyping array
2017-04-10	28039263	Wheeler HE	2016-12-30	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/28039263	Variants in WFS1 and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated Ototoxicity.	Cisplatin-induced ototoxicity	511 European ancestry testicular cancer survivor individuals	238 children	3p26.3	3	2005081	intergenic	RPL21P17 - RN7SKP144	727810	106479159		98912	83896	rs13067896-A	rs13067896	0	13067896	intergenic_variant	1	NR	7E-6	5.154901959985743		4.494	z score decrease	Illumina [5060354] (imputed)	N	ototoxicity, response to cisplatin	http://www.ebi.ac.uk/efo/EFO_0006951, http://purl.obolibrary.org/obo/GO_0072718	GCST003898	Genome-wide genotyping array
2017-04-10	28039263	Wheeler HE	2016-12-30	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/28039263	Variants in WFS1 and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated Ototoxicity.	Cisplatin-induced ototoxicity	511 European ancestry testicular cancer survivor individuals	238 children	3p26.3	3	2002712	intergenic	RPL21P17 - RN7SKP144	727810	106479159		96543	86265	rs35367356-A	rs35367356	0	35367356	intergenic_variant	1	NR	7E-6	5.154901959985743		4.492	z score decrease	Illumina [5060354] (imputed)	N	ototoxicity, response to cisplatin	http://www.ebi.ac.uk/efo/EFO_0006951, http://purl.obolibrary.org/obo/GO_0072718	GCST003898	Genome-wide genotyping array
2017-04-10	28039263	Wheeler HE	2016-12-30	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/28039263	Variants in WFS1 and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated Ototoxicity.	Cisplatin-induced ototoxicity	511 European ancestry testicular cancer survivor individuals	238 children	12q24.22	12	116702884	intergenic	MAP1LC3B2 - C12orf49	643246	79794		126264	10436	rs10850703-A	rs10850703	0	10850703	non_coding_transcript_exon_variant	1	NR	8E-6	5.096910013008056		4.472	z score increase	Illumina [5060354] (imputed)	N	ototoxicity, response to cisplatin	http://www.ebi.ac.uk/efo/EFO_0006951, http://purl.obolibrary.org/obo/GO_0072718	GCST003898	Genome-wide genotyping array
2017-04-10	28039263	Wheeler HE	2016-12-30	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/28039263	Variants in WFS1 and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated Ototoxicity.	Cisplatin-induced ototoxicity	511 European ancestry testicular cancer survivor individuals	238 children	11p15.4	11	3128167	OSBPL5	OSBPL5			114879			rs1466045-A	rs1466045	0	1466045	intron_variant	0	NR	8E-6	5.096910013008056		4.46	z score increase	Illumina [5060354] (imputed)	N	ototoxicity, response to cisplatin	http://www.ebi.ac.uk/efo/EFO_0006951, http://purl.obolibrary.org/obo/GO_0072718	GCST003898	Genome-wide genotyping array
2017-04-10	28039263	Wheeler HE	2016-12-30	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/28039263	Variants in WFS1 and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated Ototoxicity.	Cisplatin-induced ototoxicity	511 European ancestry testicular cancer survivor individuals	238 children	6p22.2	6	26293110	intergenic	TRX-CAT1-3 - TRR-TCG4-1	7210	7232		6513	6567	rs7746807-A	rs7746807	0	7746807	intergenic_variant	1	NR	8E-6	5.096910013008056		4.46	z score increase	Illumina [5060354] (imputed)	N	ototoxicity, response to cisplatin	http://www.ebi.ac.uk/efo/EFO_0006951, http://purl.obolibrary.org/obo/GO_0072718	GCST003898	Genome-wide genotyping array
2017-04-10	28039263	Wheeler HE	2016-12-30	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/28039263	Variants in WFS1 and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated Ototoxicity.	Cisplatin-induced ototoxicity	511 European ancestry testicular cancer survivor individuals	238 children	5q35.2	5	176485993	UBXD8	FAF2			23197			rs3888233-A	rs3888233	0	3888233	intron_variant	0	NR	9E-6	5.045757490560675		4.451	z score increase	Illumina [5060354] (imputed)	N	ototoxicity, response to cisplatin	http://www.ebi.ac.uk/efo/EFO_0006951, http://purl.obolibrary.org/obo/GO_0072718	GCST003898	Genome-wide genotyping array
2017-04-10	28039263	Wheeler HE	2016-12-30	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/28039263	Variants in WFS1 and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated Ototoxicity.	Cisplatin-induced ototoxicity	511 European ancestry testicular cancer survivor individuals	238 children	4q13.1	4	60971415	intergenic	MIR548AG1 - LOC105377249	100616450	105377249		48731	172273	rs1906073-A	rs1906073	0	1906073	intergenic_variant	1	NR	9E-6	5.045757490560675		4.438	z score increase	Illumina [5060354] (imputed)	N	ototoxicity, response to cisplatin	http://www.ebi.ac.uk/efo/EFO_0006951, http://purl.obolibrary.org/obo/GO_0072718	GCST003898	Genome-wide genotyping array
2017-04-10	28039263	Wheeler HE	2016-12-30	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/28039263	Variants in WFS1 and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated Ototoxicity.	Cisplatin-induced ototoxicity	511 European ancestry testicular cancer survivor individuals	238 children	12q13.13	12	51216581	POU6F1	POU6F1			5463			rs7399018-T	rs7399018	0	7399018	intron_variant	0	NR	9E-6	5.045757490560675		4.438	z score increase	Illumina [5060354] (imputed)	N	ototoxicity, response to cisplatin	http://www.ebi.ac.uk/efo/EFO_0006951, http://purl.obolibrary.org/obo/GO_0072718	GCST003898	Genome-wide genotyping array
2017-04-10	28039263	Wheeler HE	2016-12-30	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/28039263	Variants in WFS1 and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated Ototoxicity.	Cisplatin-induced ototoxicity	511 European ancestry testicular cancer survivor individuals	238 children	3p26.3	3	2006661	intergenic	RPL21P17 - RN7SKP144	727810	106479159		100492	82316	rs73807529-A	rs73807529	0	73807529	intergenic_variant	1	NR	9E-6	5.045757490560675		4.435	z score decrease	Illumina [5060354] (imputed)	N	ototoxicity, response to cisplatin	http://www.ebi.ac.uk/efo/EFO_0006951, http://purl.obolibrary.org/obo/GO_0072718	GCST003898	Genome-wide genotyping array
2011-05-11	21483023	Wu X	2011-04-11	J Natl Cancer Inst	www.ncbi.nlm.nih.gov/pubmed/21483023	Genome-wide association study of survival in non-small cell lung cancer patients receiving platinum-based chemotherapy.	Response to platinum-based chemotherapy in non-small-cell lung cancer	327 European ancestry individuals	735 European ancestry individuals	12q23.3	12	108305255	CMKLR1	CMKLR1			1240			rs1878022-?	rs1878022	0	1878022	intron_variant	0	NR	5E-7	6.301029995663981		1.33	[1.19-1.48]	Illumina [307260]	N	response to platinum based chemotherapy, non-small cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0004647, http://www.ebi.ac.uk/efo/EFO_0003060	GCST001035	Genome-wide genotyping array
2012-10-23	22872573	Hu L	2012-08-07	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/22872573	Genome-wide association study of prognosis in advanced non-small cell lung cancer patients receiving platinum-based chemotherapy.	Response to platinum-based chemotherapy in non-small-cell lung cancer	528 Han Chinese ancestry cases	340 Han Chinese ancestry cases, 409 European ancestry cases	5p14.1	5	26389153	CDH9	RNU4-43P - CCNB3P1	106481185	100131678		376128	350600	rs969088-C	rs969088	0	969088	intron_variant	1	NR	2E-6	5.698970004336019	(Han Chinese)	1.43	[1.24-1.66]	NR [576351]	N	response to platinum based chemotherapy, non-small cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0004647, http://www.ebi.ac.uk/efo/EFO_0003060	GCST001629	Genome-wide genotyping array
2012-10-23	22872573	Hu L	2012-08-07	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/22872573	Genome-wide association study of prognosis in advanced non-small cell lung cancer patients receiving platinum-based chemotherapy.	Response to platinum-based chemotherapy in non-small-cell lung cancer	528 Han Chinese ancestry cases	340 Han Chinese ancestry cases, 409 European ancestry cases	7q31.31	7	118351841	CFTR, ST7, WNT2	LOC102724495 - LOC105375471	102724495	105375471		28951	75199	rs41997-A	rs41997	0	41997	intron_variant	1	NR	4E-7	6.3979400086720375	(Han Chinese)	1.52	[1.28-1.79]	NR [576351]	N	response to platinum based chemotherapy, non-small cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0004647, http://www.ebi.ac.uk/efo/EFO_0003060	GCST001629	Genome-wide genotyping array
2012-10-23	22872573	Hu L	2012-08-07	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/22872573	Genome-wide association study of prognosis in advanced non-small cell lung cancer patients receiving platinum-based chemotherapy.	Response to platinum-based chemotherapy in non-small-cell lung cancer	528 Han Chinese ancestry cases	340 Han Chinese ancestry cases, 409 European ancestry cases	9p21.3	9	23426273	HuB	LOC107987055 - LOC105369298	107987055	105369298		321098	56467	rs12000445-A	rs12000445	0	12000445	intron_variant	1	NR	7E-6	5.154901959985743	(Han Chinese)	1.49	[1.25-1.75]	NR [576351]	N	response to platinum based chemotherapy, non-small cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0004647, http://www.ebi.ac.uk/efo/EFO_0003060	GCST001629	Genome-wide genotyping array
2012-10-23	22872573	Hu L	2012-08-07	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/22872573	Genome-wide association study of prognosis in advanced non-small cell lung cancer patients receiving platinum-based chemotherapy.	Response to platinum-based chemotherapy in non-small-cell lung cancer	528 Han Chinese ancestry cases	340 Han Chinese ancestry cases, 409 European ancestry cases	5p14.1	5	26389153	CDH9	RNU4-43P - CCNB3P1	106481185	100131678		376128	350600	rs969088-C	rs969088	0	969088	intron_variant	1	NR	3E-6	5.522878745280337	(Han Chinese + EA)	1.4	[1.22-1.61]	NR [576351]	N	response to platinum based chemotherapy, non-small cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0004647, http://www.ebi.ac.uk/efo/EFO_0003060	GCST001629	Genome-wide genotyping array
2012-10-23	22872573	Hu L	2012-08-07	Clin Cancer Res	www.ncbi.nlm.nih.gov/pubmed/22872573	Genome-wide association study of prognosis in advanced non-small cell lung cancer patients receiving platinum-based chemotherapy.	Response to platinum-based chemotherapy in non-small-cell lung cancer	528 Han Chinese ancestry cases	340 Han Chinese ancestry cases, 409 European ancestry cases	14q24.3	14	78068563	NRXN3, SKIIP, SNW1, ALKBH1	NRXN3			9369			rs3850370-C	rs3850370	0	3850370	intergenic_variant	0	NR	4E-6	5.3979400086720375	(Han Chinese + EA)	1.31	[1.17-1.47]	NR [576351]	N	response to platinum based chemotherapy, non-small cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0004647, http://www.ebi.ac.uk/efo/EFO_0003060	GCST001629	Genome-wide genotyping array
2016-01-30	25823687	Cao S	2015-03-31	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/25823687	Genome-wide association study of myelosuppression in non-small-cell lung cancer patients with platinum-based chemotherapy.	Platinum-induced myelosuppression in non-small cell lung cancer	328 Han Chinese ancestry cases	876 Han Chinese ancestry cases	2q24.3	2	163470244	FIGN	LOC107985829 - FIGN	107985829	55137		12789	132367	rs13014982-?	rs13014982	0	13014982	intergenic_variant	1		7E-6	5.154901959985743	(variant homozygote model)			Affymetrix [588732]	N	myelosuppression, response to platinum based chemotherapy, non-small cell lung carcinoma	http://www.ebi.ac.uk/efo/EFO_0007053, http://www.ebi.ac.uk/efo/EFO_0004647, http://www.ebi.ac.uk/efo/EFO_0003060	GCST002833	Genome-wide genotyping array
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	289 European ancestry women	NA	3q23	3	141643383	intergenic	RASA2 - LOC646730	5922	646730		28020	19816	rs295315-?	rs295315	0	295315	regulatory_region_variant	1	NR	8E-7	6.096910013008056		1.82		Illumina [636555]	N	overall survival, ovarian carcinoma, response to cisplatin, response to paclitaxel	http://www.ebi.ac.uk/efo/EFO_0000638, http://www.ebi.ac.uk/efo/EFO_0001075, http://purl.obolibrary.org/obo/GO_0072718, http://purl.obolibrary.org/obo/GO_1901555	GCST004896	Genome-wide genotyping array
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	289 European ancestry women	NA	10q23.1	10	80608465	SH2D4B	SH2D4B			387694			rs17693104-?	rs17693104	0	17693104	intron_variant	0	NR	8E-7	6.096910013008056		1.65		Illumina [636555]	N	overall survival, ovarian carcinoma, response to cisplatin, response to paclitaxel	http://www.ebi.ac.uk/efo/EFO_0000638, http://www.ebi.ac.uk/efo/EFO_0001075, http://purl.obolibrary.org/obo/GO_0072718, http://purl.obolibrary.org/obo/GO_1901555	GCST004896	Genome-wide genotyping array
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	289 European ancestry women	NA	3q23	3	141658488	LOC646730	RASA2 - LOC646730	5922	646730		43125	4711	rs868767-?	rs868767	0	868767	intergenic_variant	1	NR	2E-6	5.698970004336019		2.12		Illumina [636555]	N	overall survival, ovarian carcinoma, response to cisplatin, response to paclitaxel	http://www.ebi.ac.uk/efo/EFO_0000638, http://www.ebi.ac.uk/efo/EFO_0001075, http://purl.obolibrary.org/obo/GO_0072718, http://purl.obolibrary.org/obo/GO_1901555	GCST004896	Genome-wide genotyping array
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	289 European ancestry women	NA	20p11.21	20	24451198	intergenic	GAPDHP53 - LOC105372585	100421318	105372585		4884	17028	rs2050203-?	rs2050203	0	2050203	intergenic_variant	1	NR	4E-6	5.3979400086720375		1.78		Illumina [636555]	N	overall survival, ovarian carcinoma, response to cisplatin, response to paclitaxel	http://www.ebi.ac.uk/efo/EFO_0000638, http://www.ebi.ac.uk/efo/EFO_0001075, http://purl.obolibrary.org/obo/GO_0072718, http://purl.obolibrary.org/obo/GO_1901555	GCST004896	Genome-wide genotyping array
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	289 European ancestry women	NA	14q32.31	14	101629499	intergenic	LOC107984698			107984698			rs11621975-?	rs11621975	0	11621975	intron_variant	0	NR	5E-6	5.301029995663981		2.31		Illumina [636555]	N	overall survival, ovarian carcinoma, response to cisplatin, response to paclitaxel	http://www.ebi.ac.uk/efo/EFO_0000638, http://www.ebi.ac.uk/efo/EFO_0001075, http://purl.obolibrary.org/obo/GO_0072718, http://purl.obolibrary.org/obo/GO_1901555	GCST004896	Genome-wide genotyping array
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	289 European ancestry women	NA	12q23.2	12	102981636	intergenic	ASCL1 - C12orf42	429	374470		21120	66033	rs17548007-?	rs17548007	0	17548007	intergenic_variant	1	NR	5E-6	5.301029995663981		1.86		Illumina [636555]	N	overall survival, ovarian carcinoma, response to cisplatin, response to paclitaxel	http://www.ebi.ac.uk/efo/EFO_0000638, http://www.ebi.ac.uk/efo/EFO_0001075, http://purl.obolibrary.org/obo/GO_0072718, http://purl.obolibrary.org/obo/GO_1901555	GCST004896	Genome-wide genotyping array
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	289 European ancestry women	NA	8q21.13	8	81290982	intergenic	FABP5 - LOC105375925	2171	105375925		6205	42523	rs202280-?	rs202280	0	202280	regulatory_region_variant	1	NR	6E-6	5.221848749616356		2.0		Illumina [636555]	N	overall survival, ovarian carcinoma, response to cisplatin, response to paclitaxel	http://www.ebi.ac.uk/efo/EFO_0000638, http://www.ebi.ac.uk/efo/EFO_0001075, http://purl.obolibrary.org/obo/GO_0072718, http://purl.obolibrary.org/obo/GO_1901555	GCST004896	Genome-wide genotyping array
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	289 European ancestry women	NA	10p12.1	10	26722183	PDSS1	PDSS1			23590			rs1564271-?	rs1564271	0	1564271	intron_variant	0	NR	9E-6	5.045757490560675		1.62		Illumina [636555]	N	overall survival, ovarian carcinoma, response to cisplatin, response to paclitaxel	http://www.ebi.ac.uk/efo/EFO_0000638, http://www.ebi.ac.uk/efo/EFO_0001075, http://purl.obolibrary.org/obo/GO_0072718, http://purl.obolibrary.org/obo/GO_1901555	GCST004896	Genome-wide genotyping array
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	289 European ancestry women	NA	11q14.1	11	78008566	intergenic	INTS4 - KCTD14	92105	65987		13717	7149	rs10899426-?	rs10899426	0	10899426	intergenic_variant	1	NR	9E-6	5.045757490560675		2.29		Illumina [636555]	N	overall survival, ovarian carcinoma, response to cisplatin, response to paclitaxel	http://www.ebi.ac.uk/efo/EFO_0000638, http://www.ebi.ac.uk/efo/EFO_0001075, http://purl.obolibrary.org/obo/GO_0072718, http://purl.obolibrary.org/obo/GO_1901555	GCST004896	Genome-wide genotyping array
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Overall survival in serous epithelial ovarian cancer treated with paclitaxel and cisplatin	289 European ancestry women	NA	6p25.3	6	1492427	intergenic	LOC102723944, LOC105374883			102723944, 105374883			rs4618572-?	rs4618572	0	4618572	intergenic_variant	0	NR	9E-6	5.045757490560675		1.86		Illumina [636555]	N	overall survival, ovarian carcinoma, response to cisplatin, response to paclitaxel	http://www.ebi.ac.uk/efo/EFO_0000638, http://www.ebi.ac.uk/efo/EFO_0001075, http://purl.obolibrary.org/obo/GO_0072718, http://purl.obolibrary.org/obo/GO_1901555	GCST004896	Genome-wide genotyping array
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	147 European ancestry women	NA	11q14.1	11	78008566	intergenic	INTS4 - KCTD14	92105	65987		13717	7149	rs10899426-?	rs10899426	0	10899426	intergenic_variant	1	NR	2E-7	6.698970004336019		2.74		Illumina [636555]	N	progression free survival, ovarian carcinoma, response to cisplatin, response to paclitaxel	http://www.ebi.ac.uk/efo/EFO_0004920, http://www.ebi.ac.uk/efo/EFO_0001075, http://purl.obolibrary.org/obo/GO_0072718, http://purl.obolibrary.org/obo/GO_1901555	GCST004897	Genome-wide genotyping array
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	147 European ancestry women	NA	11p15.3	11	13492506	PTH	PTH			5741			rs6256-?	rs6256	0	6256	stop_gained	0	NR	1E-6	6.0		1.93		Illumina [636555]	N	progression free survival, ovarian carcinoma, response to cisplatin, response to paclitaxel	http://www.ebi.ac.uk/efo/EFO_0004920, http://www.ebi.ac.uk/efo/EFO_0001075, http://purl.obolibrary.org/obo/GO_0072718, http://purl.obolibrary.org/obo/GO_1901555	GCST004897	Genome-wide genotyping array
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	147 European ancestry women	NA	11p15.3	11	13553087	intergenic	PTH - HMGN2P36	5741	100874480		56912	57308	rs10832063-?	rs10832063	0	10832063	intergenic_variant	1	NR	5E-6	5.301029995663981		1.8		Illumina [636555]	N	progression free survival, ovarian carcinoma, response to cisplatin, response to paclitaxel	http://www.ebi.ac.uk/efo/EFO_0004920, http://www.ebi.ac.uk/efo/EFO_0001075, http://purl.obolibrary.org/obo/GO_0072718, http://purl.obolibrary.org/obo/GO_1901555	GCST004897	Genome-wide genotyping array
2017-10-20	28935272	Moore KN	2017-09-18	Gynecol Oncol	www.ncbi.nlm.nih.gov/pubmed/28935272	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.	Progression free survival in serous epithelial ovarian cancer treated with carboplatin and paclitaxel	147 European ancestry women	NA	11p15.3	11	13401400	BTBD10	BTBD10			84280			rs10500780-?	rs10500780	0	10500780	intron_variant	0	NR	5E-6	5.301029995663981		1.79		Illumina [636555]	N	progression free survival, ovarian carcinoma, response to cisplatin, response to paclitaxel	http://www.ebi.ac.uk/efo/EFO_0004920, http://www.ebi.ac.uk/efo/EFO_0001075, http://purl.obolibrary.org/obo/GO_0072718, http://purl.obolibrary.org/obo/GO_1901555	GCST004897	Genome-wide genotyping array
